Jennifer Doudna won the Nobel Prize for gene editing and went on Bloomberg to say the chatbots everyone is betting on cannot innovate at all. Every promise Silicon Valley is making about AI curing disease just hit the one person qualified to check it. She has spent her whole career inside the actual frontier of curing disease. So when she talks about what AI can and cannot do in biology, she is not guessing. She is reporting from inside the lab. Her words were blunt. She is not seeing chatbots innovate. They summarize data. They write reports. They do not come up with a brand new idea nobody has ever had. Then the interviewer pushed. So you're saying AI can't innovate? Doudna did not flinch. She does not know if it can't. She just does not see it doing it right now. This lands harder when you remember who is making the opposite case. Sam Altman says AI will eliminate disease within five years. Larry Ellison says AI will cure cancer in a 48 hour window. An OpenAI executive even floated that the company should get a cut of sales on any drug discovered through ChatGPT. Doudna answered that in two words. Good luck. Even the cancer specialists Altman is selling to keep warning that cancer is not one disease but hundreds, each needing its own cure, and that compute does not skip the years of lab work. Her reason is simpler. Biology is hard. You cannot simulate your way to an understanding of the human body. The people promising cures are the ones selling the tool. The person who actually won a Nobel building them is telling you it has not happened yet. Source: Bloomberg Originals Watch the full video on their official channel.